Verrica Pharmaceuticals Inc.
VRCANASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $75.21M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $3.28$9.82
- Volume (live)
- -
- Avg. volume (3M)
- 55.12K
Verrica Pharmaceuticals (VRCA) Stock Price & Financial Analysis
Verrica Pharmaceuticals Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $3.40 - $3.76 |
|---|---|
| 52-Week High | $9.82 |
| 52-Week Low | $3.28 |
| Open | $3.76 |
| Volume (last close) | 21.00K |
| Average Volume (3M) | 55.12K |
| Revenue (TTM) | 30.32M |
|---|---|
| Net Income (TTM) | -31.18M |
| Free Cash Flow (TTM) | -13.35M |
| EPS (TTM) | −$1.99 |
| Profit Margin | -102.84% |
| Operating Margin | -87.18% |
| Return on Equity (ROE) | -724.01% |
| Debt to Equity | 0.42 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 75.21M |
|---|---|
| Shares Outstanding | 21.31M |
| Price to Sales (P/S) | 2.48 |
| Price to Book (P/B) | 17.46 |
| EV/EBITDA | -2.87 |
| 50-Day MA | $4.63 |
|---|---|
| 200-Day MA | $5.79 |
| 1-Year Change | −3.04% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Verrica Pharmaceuticals at a Glance
As of the Oct 23, 2026 close, Verrica Pharmaceuticals (VRCA) has a market capitalization of $75.21M. The stock trades at 2.5× sales. Over the trailing twelve months it lost $31.18M on revenue of $30.32M and burned $13.35M of free cash flow. Revenue grew 106.2% year over year.
As of its latest reported balance sheet, it holds $11.20M in cash and securities against $1.81M of debt, a net cash position of $9.39M.
Verrica Pharmaceuticals does not currently pay a dividend.
The share price is down 3.0% over the past year. At $3.53 (the Oct 23, 2026 close) it sits near the bottom of its 52-week range of $3.28 to $9.82, below its 200-day moving average of $5.79.
Based on 1 professional analyst rating from the past 90 days, the consensus is Hold.
Frequently Asked Questions About Verrica Pharmaceuticals
What is the current stock price for VRCA?
As of the Oct 23, 2026 close, VRCA stock trades at $3.53. The 52-week range is $3.28–$9.82, with a day range of $3.40–$3.76.
What is the P/E ratio for VRCA?
The P/E ratio (Price-to-Earnings) for VRCA is shown in the Key Statistics section. This valuation metric helps compare Verrica Pharmaceuticals Inc. to industry peers.
Does VRCA pay dividends?
Verrica Pharmaceuticals does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for VRCA?
Based on ratings from 1 professional analyst over the last 90 days, the consensus for VRCA is Hold.
What is the market cap of VRCA?
As of the Oct 23, 2026 close, Verrica Pharmaceuticals's market capitalization is $75.2M, classifying it as a micro-cap company. Verrica Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.